Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
1369–1404
Headlines
5511
Sources here
14
Companies here
32
Current section United States Medical Devices news

Chronological news

Earlier headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

IRadimed (IRMD) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Friday, July 31, 2026 at 11:00 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Roger SusiChief Financial Officer - John Glenn TAKEAWAYS Revenue -- $20.5 million, representing a 0.5% increase from $20.4 million in the second …

IRMD main company
Sharemaestro market context Price below Trend Line 52 weeks +21.1% · Next-week setup positive 59.7% IRMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Enovis (ENOV) Stock Eyes Margin Gains as Free Cash Flow Improves

Enovis (ENOV) stock saw a modest 1.1% increase despite reporting significant improvements in its Q2 financials, including a narrowed net loss, improved gross and EBITDA margins, and positive free cash flow of US$31 million. The company's future prospects hinge on translating operational progress into …

ENOV main company
Sharemaestro market context Trend signal active 52 weeks -17.1% ENOV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Integer Holdings Corp (ITGR) Stock News Today

This article provides recent stock news for Integer Holdings Corp (ITGR), including its current stock price and market capitalization. It highlights related news such as Stryker Corp (SYK) and Intuitive Surgical Inc (ISRG) stock movements on August 3rd. The page also features an overview …

ITGR main company
Sharemaestro market context Trend signal active 52 weeks +13.3% · Next-week setup positive 57.4% ITGR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Apyx Medical Corp (APYX) Stock News Today

This page provides an overview of Apyx Medical Corp (APYX) stock information, including its current trading price, market cap, and links to news, analysis, financials, and other company data. It notes that more earnings news will be coming soon for the company.

APYX main company
Sharemaestro market context Trend signal ended 52 weeks +45.0% APYX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Apyx Medical (NASDAQ:APYX) Issues Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Apyx Medical (NASDAQ:APYX) reported its quarterly earnings, beating analyst expectations with an adjusted loss of $0.07 per share against a projected $0.08 loss and revenue of $13.88 million. This revenue marked a 22% increase year-over-year, driven by a significant rise in surgical aesthetics sales …

APYX main company
Sharemaestro market context Trend signal ended 52 weeks +45.0% APYX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Orthofix Medical Inc. (OFIX): Analyzing the 34.43% Potential Upside in the Medical Devices Sector

Orthofix Medical Inc. (NASDAQ: OFIX) is a medical devices company with a projected 34.43% potential upside, according to analyst consensus. Despite financial challenges like negative EPS and ROE, the company is seen as undergoing a transformation with strategic investments in product development, particularly in …

OFIX main company
Sharemaestro market context Price below Trend Line 52 weeks -28.9% OFIX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

STERIS plc (Ireland) (STE) Stock Forecasts

STERIS plc (STE) is a medical technology company specializing in sterilization services and infection prevention, holding a leading position in contract sterilization. A recent Morningstar report highlights the company's healthy fundamentals, which are enabling accelerated share repurchases and increased investment. The report provides a …

STE main company
Sharemaestro market context Price above Trend Line 52 weeks -6.4% STE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Medtronic (MDT) Wins Expanded CE Mark For Affera System In Ventricular Arrhythmias

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Medtronic (NYSE:MDT) receives expanded CE Mark indication for its Affera Mapping and Ablation System and Sphere-9 Catheter for ventricular arrhythmia treatment. The Sphere-9 catheter …

MDT main company
Sharemaestro market context Price above Trend Line 52 weeks +0.7% MDT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Piper Sandler cuts CVRx stock rating on sales, reimbursement issues

Piper Sandler downgraded CVRx Inc (NASDAQ:CVRX) to Neutral from Overweight and lowered its price target to $4.00 from $12.00, citing sales force issues and challenges in obtaining consistent reimbursement from its largest payer. While CVRx's second-quarter revenue surpassed estimates, the company reduced its full-year …

CVRX main company
Sharemaestro market context Price below Trend Line 52 weeks -60.5% CVRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Insider Selling: Alphatec (NASDAQ:ATEC) General Counsel Sells 8,168 Shares

Alphatec (NASDAQ:ATEC) General Counsel Tyson Eliot Marshall sold 8,168 shares of the company's stock, valued at $78,821.20, on August 5th. This transaction was part of a pre-arranged Rule 10b5-1 plan to cover tax withholding obligations from vested equity awards. Despite this insider sale, Alphatec …

ATEC main company
Sharemaestro market context Price below Trend Line 52 weeks -39.3% ATEC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CVRx (CVRX) Stock Reels From Guidance Cut And Cash Burn Fears

CVRx (CVRX) stock dropped almost 60% after cutting its 2026 revenue guidance to US$58m-US$60m and providing softer Q3 guidance. Despite strong Q2 revenue of US$15.7m and high gross margins of 87%, the company reported a US$14.0m net loss and continues to burn cash, raising …

CVRX main company
Sharemaestro market context Price below Trend Line 52 weeks -60.5% CVRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Alamar Biosciences, Inc. - Class A common stock (Nasdaq:ALMR) Stock Quote

This page provides a stock quote for Alamar Biosciences, Inc. (Nasdaq: ALMR), showing its current trading price, daily performance, and key financial metrics like volume and trading ranges. It also lists recent news, including Q2 2026 earnings, partnership announcements, and new product launches, highlighting …

ALMR main company
Sharemaestro market context Stored weekly price path 18 weeks +50.7% ALMR stored weekly price path from 17 Apr 2026 to 14 Aug 2026

A Look at Glaukos Corp (GKOS) After 5.3% Gain -- GF Value $147.7

Glaukos Corp (GKOS) recently saw a 5.3% stock gain, closing at $180.02, but GuruFocus assesses it as 21.8% overvalued with a GF Value of $147.78. Despite a strong GF Score™ of 78/100 and high growth potential (9/10), the company faces significant challenges with low …

GKOS main company
Sharemaestro market context Trend signal active 52 weeks +96.0% · Next-week setup positive 56.5% GKOS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Brainsway Ltd (BWAY) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Brainsway Ltd (BWAY), highlighting its strong earnings forecast score and analyst ratings. The average price target for BWAY is $23.50, with analysts largely recommending a "Strong Buy." The report also details past and projected EPS and revenue …

BWAY main company
Sharemaestro market context Trend signal active 52 weeks +114.7% BWAY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Conmed Corp (CNMD) Earnings Forecast: Future EPS & Revenue Growth Estimates

Conmed Corp (CNMD) has an earnings forecast score of 5.71, ranking 183 out of 200 in its industry, with an average analyst price target of $52.00. Analysts currently recommend a "Hold" rating for the stock. The company's expected revenue for the next quarter is …

CNMD main company
Sharemaestro market context Trend signal started 52 weeks -9.3% · Next-week setup negative 40.5% CNMD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Cerus Corp (CERS) Stock News Today

This page provides the latest news and information for Cerus Corp (CERS) stock on TradingKey, a financial information platform. As of August 7th, Cerus Corp's stock closed at $2.350, up 1.29%. The platform also offers an overview, news and analysis, financial data, stock score, …

CERS main company
Sharemaestro market context Trend signal active 52 weeks +135.6% CERS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Trinity Biotech PLC (TRIB) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Trinity Biotech PLC (TRIB), focusing on future EPS and revenue growth estimates. It includes current stock information, market cap, and a comparison with peer companies in the healthcare equipment sector. The data presented was last updated on …

TRIB main company
Sharemaestro market context Price below Trend Line 52 weeks -75.2% · Next-week setup negative 37.4% TRIB stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Price to earnings forward of TriSalus Life Sciences, Inc. – NASDAQ:TLSIW

This page provides financial information for TriSalus Life Sciences, Inc. (NASDAQ: TLSIW), focusing on its price-to-earnings forward ratio. The content indicates that the market was closed with no trades at the time of viewing, and includes copyright information from FactSet, American Bankers Association, and …

TLSI main company
Sharemaestro market context Price above Trend Line 52 weeks +4.4% TLSI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Osisko Metals (TSX:OM) Is Up 20.8% After Reporting Deepening 2026 Losses Has The Bull Case Changed?

Osisko Metals Incorporated reported second-quarter 2026 results showing a net loss of C$84.13 million, versus net income of C$0.796 million in the same period a year earlier, with basic and diluted loss per share from continuing operations of C$0.11. Over the first six months …

OM mentioned
Sharemaestro market context Trend signal active 52 weeks -68.2% · Next-week setup negative 42.8% OM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Tandem Diabetes Care, Inc. Stock 12‑Month Price Target Raised to $29.5, Implies 57% Upside

Analysts have raised the average 12-month price target for Tandem Diabetes Care, Inc. (TNDM) stock to $29.5, up from $29.19. This new target suggests a potential upside of approximately 57% from its August 6th closing price. The consensus rating among 22 analysts remains a …

TNDM main company
Sharemaestro market context Price above Trend Line 52 weeks +90.4% TNDM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Beta Bionics (NASDAQ:BBNX) Shares Up 13.7% - Should You Buy?

Beta Bionics (NASDAQ:BBNX) saw its shares surge by 13.7% to $16.05, trading above its 50-day and 200-day moving averages, though its high beta of 3.13 indicates significant volatility. Analysts hold a "Moderate Buy" consensus with a $20.10 price target, despite one firm issuing a …

BBNX main company
Sharemaestro market context Trend signal active 52 weeks +3.0% BBNX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Avanos Medical Inc (AVNS) Earnings Forecast: Future EPS & Revenue Growth Estimates

Avanos Medical Inc (AVNS) has an earnings forecast score of 6.00, placing it 174th in the Healthcare Equipment & Supplies industry. Analysts have set a target price of $14.00 for AVNS, with one analyst recommending a "Hold" rating. The company's expected revenue for the …

AVNS main company
Sharemaestro market context Trend signal active 51 weeks +131.0% AVNS stored weekly price path from 8 Aug 2025 to 24 Jul 2026

Accuray Transfers Listing to Nasdaq Capital Market

Accuray (ARAY) has received Nasdaq approval to transfer its common stock listing from the Nasdaq Global Select Market to the Nasdaq Capital Market, effective August 6, 2026. This transfer grants the company an additional 180 days, until February 1, 2027, to meet Nasdaq's minimum …

ARAY main company
Sharemaestro market context Price below Trend Line 52 weeks -82.5% · Next-week setup negative 43.7% ARAY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PODD SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Insulet (PO

Faruqi & Faruqi, LLP is reminding investors of the August 31, 2026 deadline to seek lead plaintiff status in a federal securities class action lawsuit against Insulet Corporation (NASDAQ: PODD). The lawsuit alleges that Insulet made false and misleading statements about defective manufacturing controls …

PODD main company
Sharemaestro market context Price below Trend Line 52 weeks -56.7% · Next-week setup negative 41.7% PODD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PODD INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Insulet (PODD) Investors of Securities Class Action Lawsuit Deadline on August 31, 2026

Faruqi & Faruqi, LLP is investigating potential claims against Insulet Corporation (NASDAQ: PODD) and reminds investors of the August 31, 2026 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit. The lawsuit alleges Insulet made false and/or misleading …

PODD main company
Sharemaestro market context Price below Trend Line 52 weeks -56.7% · Next-week setup negative 41.7% PODD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Treace Medical Concepts (NASDAQ:TMCI) Posts Quarterly Earnings Results, Beats Estimates By $0.06 EPS

Treace Medical Concepts (NASDAQ:TMCI) announced its quarterly earnings, reporting an adjusted loss of $0.24 per share, surpassing the consensus estimate of a $0.30 loss, with revenues of $45.38 million beating the $44.02 million forecast. The company raised its 2026 revenue guidance to $204 million–$212 …

TMCI main company
Sharemaestro market context Trend signal active 52 weeks -37.8% TMCI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Penumbra Inc (PEN) Stock News Today

This article provides current stock information for Penumbra Inc (PEN), including its latest stock price, market capitalization, and P/E ratio. It notes that this page will feature news, earnings, analyst ratings, and key developments related to PEN stock, with more updates expected soon. The …

PEN main company
Sharemaestro market context Price below Trend Line 52 weeks +23.5% PEN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AdaptHealth Corp. Just Missed Earnings; Here's What Analysts Are Forecasting Now

AdaptHealth Corp. (NASDAQ:AHCO) shares plunged 43% after missing Q2 earnings estimates, with revenues falling 13% short and the company reporting a statutory loss instead of a forecasted profit. Analysts have significantly cut revenue forecasts and now anticipate a loss for 2026, leading to a …

AHCO main company
Sharemaestro market context Price below Trend Line 52 weeks -39.5% AHCO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Canaccord raises Artivion stock price target on acquisition, PMA approval

Canaccord raised its price target for Artivion Inc. (NYSE:AORT) to $39 from $36, maintaining a Buy rating, following the company's acquisition of Endospan and PMA approval for AMDS. Artivion's second-quarter revenue of $125.8 million and adjusted EBITDA of $26.4 million both surpassed analyst estimates, …

AORT main company
Sharemaestro market context Price below Trend Line 52 weeks -35.0% AORT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Avior Wealth Management LLC Lowers Stake in Abbott Laboratories $ABT

Avior Wealth Management LLC reduced its stake in Abbott Laboratories (NYSE:ABT) by 47.5% in the second quarter, selling 19,199 shares and retaining 21,257 shares valued at $1.93 million. Despite this, analysts maintain a "Moderate Buy" rating for Abbott with an average price target of …

ABT main company
Sharemaestro market context Price above Trend Line 52 weeks -14.8% · Next-week setup positive 55.5% ABT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context